NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)

The NIH Directors New Innovator Award supports early stage investigators of exceptional creativity who propose bold and highly innovative research projects with the potential to produce a major impact on broad, important areas relevant to the mission of NIH. Applications in any area within the biomedical sciences are welcome. The NIH Director's New Innovator Award complements other ongoing efforts by NIH and its Institutes and Centers to fund early-stage investigators. The NIH Directors New Innovator Award is a component of the High-Risk, High-Reward Research (HRHR) Program of the NIH Common Fund.